Q2 2021

Bridging autoinflammatory and autoimmune diseases

Emad M. El-Shebiny · Enas S. Zahran · Sabry A. Shoeib · Eman S. Habib
10.1186/s43162-021-00040-5 390 المشاهدات 30 الاقتباسات
30
الاقتباسات
390
المشاهدات
الملخص

Abstract
Background
Autoimmunity is used to cause by impairment of adaptive immunity alone, whereas autoinflammatory was originally defined as a consequence of unregulated innate immunity. So, the pathogenetic mechanisms of autoimmune diseases were well-thought-out to be mediated by B and T lymphocytes. Whereas, autoinflammatory diseases were defined as unprovoked times of inflammation with the absence of a high titre of autoantibodies.

Main body of the abstract
Autoimmune and autoinflammatory diseases were split into two groups, but considering the similarities, it can be considered as only one group of diseases with a large immune pathological and clinical spectrum which involves at one end pure autoimmune diseases and the other pure autoinflammatory diseases.

Conclusions
We can safely conclude that there is bridging between autoinflammatory and autoimmune diseases.

الاستشهاد بهذا المقال (APA)
Emad, M. E., Enas, S. Z., Sabry, A. S., Eman, S. H. (2021). Bridging autoinflammatory and autoimmune diseases. The Egyptian Journal of Internal Medicine. https://doi.org/10.1186/s43162-021-00040-5
أبحاث ذات صلة
Antiangiogenic role of natural flavonoids and their molecular mechanism: an update
Gowtham Kumar Subbaraj; Yasam Santhosh Kumar; Langeswaran Kulanthaivel · 2021
34
استشهاد
391
Factors affecting glycemic control among Egyptian people with diabetes attending primary health care…
Mai Mohamed Azzam; Adel Alwehedy Ibrahim; Mohammed I. Abd El-Ghany · 2021
27
استشهاد
394
A narrative review of pox: smallpox vs monkeypox
Samiksha Jayswal; Jagdish Kakadiya · 2022
23
استشهاد
390
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically venti…
Mohammed Abdel Monem Saeed; Alaa Hussein Mohamed; Ahmed Hassan Owaynat · 2022
20
استشهاد
394
18
استشهاد
390
الوصول
عرض النص الكامل عبر DOI
نُشر في
الرقم الدولي ISSN 1110-7782
الربعية Q2
درجة المؤشر القياس العربي 94
التخصص Medicine & Health Sciences
الناشر Springer (Biomed Central Ltd.)
الدولة 🇪🇬 Egypt
عرض ملف المجلة →
المؤلفون
E
Emad M. El-Shebiny
تفاصيل النشر
السنة 2021
اللغة English
أُضيف في 14 Aug 2026